HUNTINGTON NATIONAL BANK - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 316 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.3%.

Quarter-by-quarter ownership
HUNTINGTON NATIONAL BANK ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$44,955
+11.3%
2,906
+13.0%
0.00%
Q2 2023$40,406
-2.6%
2,572
+2.1%
0.00%
Q1 2023$41,496
-31.1%
2,518
-34.7%
0.00%
-100.0%
Q4 2022$60,201
+62.7%
3,859
+36.1%
0.00%
Q3 2022$37,000
-7.5%
2,8360.0%0.00%
Q2 2022$40,000
-32.2%
2,836
-31.3%
0.00%
-100.0%
Q1 2022$59,000
+51.3%
4,126
+45.5%
0.00%
Q4 2021$39,000
-15.2%
2,836
+0.0%
0.00%
Q3 2021$46,000
-16.4%
2,835
-13.5%
0.00%
-100.0%
Q2 2021$55,000
+19.6%
3,276
+30.2%
0.00%0.0%
Q1 2021$46,0000.0%2,5170.0%0.00%0.0%
Q4 2020$46,000
+2.2%
2,5170.0%0.00%0.0%
Q3 2020$45,0000.0%2,5170.0%0.00%0.0%
Q2 2020$45,000
-48.9%
2,517
-56.4%
0.00%
-50.0%
Q1 2020$88,000
-30.2%
5,772
-10.2%
0.00%0.0%
Q4 2019$126,000
+93.8%
6,427
+68.1%
0.00%
+100.0%
Q3 2019$65,000
-42.0%
3,824
-39.4%
0.00%
-50.0%
Q2 2019$112,000
-16.4%
6,307
-4.3%
0.00%0.0%
Q1 2019$134,0006,5870.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2019
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders